Hemoglobin-based oxygen carriers camouflaged with membranes extracted from red blood cells: Optimization and assessment of functionality
Source abstract
Abstract
Despite being an indispensable clinical procedure, the transfusion of donor blood has important limitations including a short shelf-life, limited availability and specific storage requirements. Therefore, a lot of effort has been devoted to developing hemoglobin (Hb)-based oxygen carriers (HBOCs) that are able to replace or complement standard blood transfusions, especially in extreme life-threatening situations. Herein, we employed a Hb-loaded poly(lactide- co -glycolide) core which was subsequently coated with nanozymes to protect the encapsulated Hb from oxidation by reactive oxygen species. To render HBOCs with long circulation in the vasculature, which is a crucial requirement to achieve the high oxygen demands of our organism, the carrier was coated with a red blood cell-derived membrane. Three coating methods were explored and evaluated by their ability to repel the deposition of proteins and minimize their uptake by an endothelial cell line. Preservation of the oxygen carrying capacity of the membrane-coated carrier was demonstrated by an oxygen-binding and releasing assay and, the functionality resulting from the entrapped nanozymes, was shown by means of superoxide radical anion and hydrogen peroxide depletion assays. All in all, we have demonstrated the potential of the membrane-coated nanocarriers as novel oxygen carrying systems with both antioxidant and stealth properties. • Hemoglobin is encapsulated within PLGA nanoparticles to create a potential blood surrogate • Nanozymes are incorporated and provide protection towards oxidation by depleting reactive oxygen species • To achieve extended circulation in blood, the nanoparticles are coated by membranes extracted from red blood cells • The hemoglobin loaded nanoparticles are able to reversibly bind and release oxygen, before and after the membrane coating • The membrane coating is able to minimize the deposition of proteins onto the nanoparticles and reduce their cellular uptake
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Hemoglobin structure and function · Advanced Nanomaterials in Catalysis · Heme Oxygenase-1 and Carbon Monoxide
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (52)
Show source-provided references
1. Red blood cell storage time & transfusion: current practice, concerns & future perspectives
2. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin. A novel mechanism of human disease10.1001/jama.293.13.1653 ↗
3. Intrinsic toxicity of hemoglobin: how to counteract it10.1111/j.1525-1594.2008.00693.x ↗
4. Recent and prominent examples of nano- and microarchitectures as hemoglobin-based oxygen carriers10.1016/j.cis.2018.08.006 ↗
5. Heme degradation by reactive oxygen species
6. Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties10.1038/nbt0798-667 ↗
7. Hemoglobin-superoxide dismutase-chemical linkages that create a dual-function protein10.1021/ja050339r ↗
8. Assembled hemoglobin and catalase nanotubes for the treatment of oxidative stress
9. Covalent modification is a means of regulating enzyme activity
10. Solids go bio: inorganic nanoparticles as enzyme mimics10.1002/ejic.201501237 ↗
11. Therapeutic applications of multifunctional Nanozymes10.1039/C9NR06596B ↗
12. Cerium and iron-oxide-based nanozymes in tissue engineering and regenerative medicine10.3390/catal9080691 ↗
13. Hemoglobin–Albumin cluster incorporating a Pt nanoparticle: artificial O2 carrier with antioxidant activities10.1371/journal.pone.0110541 ↗
14. Hemoglobin-based oxygen carriers incorporating nanozymes for the depletion of reactive oxygen species10.1021/acsami.0c14822 ↗
15. Optimization of hemoglobin encapsulation within Plga nanoparticles and their investigation as potential oxygen carriers10.3390/pharmaceutics13111958 ↗
16. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives10.1002/anie.200902672 ↗
17. The importance of poly(ethylene glycol) alternatives for overcoming PEG immunogenicity in drug delivery and bioconjugation10.3390/polym12020298 ↗
18. Immunogenicity of polyethylene glycol based nanomedicines: mechanisms, clinical implications and systematic approach10.1002/adtp.201900170 ↗
19. Role of CD47 as a marker of self on red blood cells10.1126/science.288.5473.2051 ↗
20. Erythrocyte-inspired delivery systems10.1002/adhm.201200138 ↗
21. Multifaceted role of glycosylation in transfusion medicine, platelets, and red blood cells10.1111/jth.14874 ↗
22. Shear stress and its effect on the interaction of myoblast cells with nanosized drug delivery vehicles10.1021/mp4001298 ↗
23. Spectrophotometry of hemoglobin: absorption spectra of bovine oxyhemoglobin, deoxyhemoglobin, carboxyhemoglobin, and methemoglobin10.1016/S0305-0491(97)00230-7 ↗
24. Haemoglobin-loaded metal organic framework-based nanoparticles camouflaged with a red blood cell membrane as potential oxygen delivery systems10.1039/D0BM01118E ↗
25. One-stage synthesis of ceria colloid solutions for biomedical use10.1134/S0012500811040070 ↗
26. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform10.1073/pnas.1106634108 ↗
27. Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles10.1039/C3NR06371B ↗
28. Biomimetic anisotropic polymeric nanoparticles coated with red blood cell membranes for enhanced circulation and toxin removal10.1126/sciadv.aay9035 ↗
29. Metal-organic framework-based oxygen carriers with antioxidant protection as a result of a Polydopamine coating10.1039/D1BM01005K ↗
30. In vitro macrophage uptake and in vivo biodistribution of PLA–PEG nanoparticles loaded with hemoglobin as blood substitutes: effect of PEG content10.1007/s10856-009-3746-9 ↗
31. Low-fouling electrosprayed hemoglobin nanoparticles with antioxidant protection as promising oxygen carriers10.1002/mabi.201900293 ↗
32. Degradation of liposomal subcompartments in Pegylated capsosomes10.1039/c1sm05623a ↗
33. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles10.1016/j.ijpharm.2005.10.010 ↗
34. Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients10.1002/cncr.22739 ↗
35. Pre-existing anti-polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a Pegylated RNA aptamer10.1016/j.jaci.2015.10.034 ↗
36. “Marker-of-Self” functionalization of nanoscale particles through a top-down cellular membrane coating approach10.1039/c3nr00015j ↗
37. A red blood cell membrane-camouflaged nanoparticle counteracts streptolysin O-mediated virulence phenotypes of invasive group A streptococcus10.3389/fphar.2017.00477 ↗
38. Broad-spectrum neutralization of pore-forming toxins with human erythrocyte membrane-coated nanosponges10.1002/adhm.201701366 ↗
39. The journey of a drug-carrier in the body: an anatomo-physiological perspective10.1016/j.jconrel.2011.09.098 ↗
40. Kinetics of blood component adsorption on poly(D,L-lactic acid) nanoparticles: evidence of complement C3 component involvement10.1002/(SICI)1097-4636(199711)37:2<229::AID-JBM12>3.0.CO;2-9 ↗
41. Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential10.1016/j.biomaterials.2007.07.029 ↗
42. Secondary-structure analysis of denatured proteins by vacuum-ultraviolet circular dichroism spectroscopy10.1529/biophysj.106.103515 ↗
43. The interplay between molten globules and heme disassociation defines human hemoglobin disassembly10.1016/j.bpj.2020.01.031 ↗
44. Poly(L-lysine) as a model drug macromolecule with which to investigate secondary structure and membrane transport, part I: physicochemical and stability studies10.1211/0022357021778556 ↗
45. Direct evidence of controlled structure reorganization in a nanoorganized polypeptide multilayer thin film10.1021/ma049136y ↗
46. Layer-by-layer assembly of biopolyelectrolytes onto thermo/Ph-responsive micro/nano-gels10.3390/ma7117472 ↗
47. Pharmacological potential of cerium oxide nanoparticles10.1039/c0nr00875c ↗
48. Superoxide dismutase: improving its pharmacological properties by conjugation with human serum albumin10.3109/10731198909118282 ↗
49. Immobilization of catalase in poly(isopropylacrylamide-co-hydroxyethylmethacrylate) thermally reversible hydrogels10.1002/(SICI)1097-0126(199909)48:9<879::AID-PI237>3.0.CO;2-N ↗
50. Red blood cell function and dysfunction: redox regulation, nitric oxide metabolism, anemia10.1089/ars.2016.6954 ↗
51. A dual-component carrier with both non-enzymatic and enzymatic antioxidant activity towards ROS depletion10.1039/C9BM00913B ↗
52. Preparation, characterization and in vivo investigation of blood-compatible hemoglobin-loaded nanoparticles as oxygen carriers10.1016/j.colsurfb.2015.12.012 ↗